All In MedTech

Device Trial Radar · NCT06948773

A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)

A Pilot Study of the Helix Surgical System in Subjects With Primary Open-Angle Glaucoma (POAG) and Cataract.

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

25

Actual

Start

May 21, 2025

Primary completion

Sep 7, 2026

Study completion Sep 7, 2026

Sponsor

Lead sponsor
Sight Sciences, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Apr 29, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study to assess the safety of the Helix Surgical System in cataract surgery and to gain early evidence of its effectiveness in lowering intraocular pressure (IOP) in subjects with mild to moderate primary open-angle glaucoma (POAG) and cataracts.

Conditions

  • Primary Open Angle Glaucoma
  • Cataract

Interventions

  • Helix Surgical SystemDevice

    A handheld device to viscodilate up to 360 degrees of Schlemm's canal and collector channels that also enables intracanalicular scaffolding procedure to restore the aqueous outflow system of a glaucomatous eye.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ≥ 20% change from baseline in mean IOP at the 3-month post-operative endpointTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Panama Eye Center

    Panama City, Panama

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.